Abstract
Objective: To investigate the effects and mechanism of lysosomal-associated protein transmem - brane 5 (LAPTM5) in doxorubicin (DOX) - induced cardiotoxicity. Methods: H9C2 cardiomyocytes were cultured in vitro and randomly divided into the SiRNA-NC group, Si-LAPTM5 group, SiRNA-NC+DOX group, and Si-LAPTM5+DOX group. SiRNA-NC (50 nmol•L-1) and Si-LAPTM5 (50 nmol•L-1) were transfected into H9C2 cardiomyocytes using LiPo6000TM transfection reagent for 4 h and then stimulated with 1 μmol•L-1 DOX or the same volume of PBS for 24 h. The successful knockdown of LAPTM5 was confirmed by Western Blot. Then, myocardial cell injury was detected by lactate dehydrogenase (LDH) and creatine kinase isoenzyme MB (CK-MB) assay kit. Cell viability was detected by the cell counting kit-8 (CCK-8) assay kit. The Fe2+ levels were measured with a FerroOrange assay kit. The level of TFR1 was detected by immunofluorescence. The level of oxidative stress was evaluated by 2′, 7′dichlorodihydrofluorescein diacetate (DCFH - DA), malondialdehyde (MDA) assay kit, NADPH oxidase assay kit, and SOD assay kit. The protein expression levels of SLC7A11, GPX4, and Ferritin were detected by Western Blot. Results: After transfection with SiLAPTM5, the expression of LAPTM5 in H9C2 cells decreased by about 75% (P<0. 05). LAPTM5 knockdown in H9C2 cells deteriorated DOX -induced cell injury and cell apoptosis, which was represented by further increased LDH level and CK - MB level, decreased cell viability, and increased TUNEL - positive cells (P<0. 05). Compared with the SiRNA - NC group, DOX increased the level of TFR1 and Fe2+. Inhibition of LAPTM5 further increased the level of TFR1 and Fe2+. Compared with the SiRNA-NC group, DOX increased reactive oxygen species (ROS) level, lipid peroxidation level, MDA content, and NADPH oxidase activity in H9C2 cardiomyocytes (P<0. 05), which were aggravated by LAPTM5 knockdown(P<0. 05). Compared with the SiRNA -NC group, DOX decreased SOD activity, which was aggravated by LAPTM5 knockdown (P<0. 05). Compared with the SiRNA-NC group, DOX decreased the expression levels of SLC7A11 and gluta-thione peroxidase 4 (GPX4) and increased the level of ferritin protein (P<0. 05). Inhibition of LAPTM5 expression further decreased the expression levels of SLC7A11 and GPX4 and increased the level of ferritin protein. Conclusion: LAPTM5 has a protective effect on doxorubicin-induced cardiotoxicity, and the mechanism may be related to the inhibition of ferroptosis. © 2025 Editorial Board of Medical Journal of Wuhan University. All rights reserved.
| Translated title of the contribution | LAPTM5 protects against doxorubicin‑induced cardiotoxicity by inhibiting ferroptosis |
|---|---|
| Original language | Chinese |
| Pages (from-to) | 829-835 |
| Number of pages | 7 |
| Journal | Medical Journal of Wuhan University |
| Volume | 46 |
| Issue number | 7 |
| Early online date | 21 Nov 2024 |
| DOIs | |
| State | Published - Jul 2025 |
Funding
国家自然科学基金区域创新发展联合基金项目(编号:U22A20269)。
Indexed by
- Scopus
Fingerprint
Dive into the research topics of 'LAPTM5 protects against doxorubicin‑induced cardiotoxicity by inhibiting ferroptosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver